- Lectures / Webinars
- FLICNA Podcasts & Journal Club
- Neurofibromatosis type 1 (NF1) updates in diagnosis and management
Neurofibromatosis type 1 (NF1) updates in diagnosis and management
New
FLICNA Podcast
Topic: Neurofibromatosis type 1 (NF1) updates in diagnosis and management
Lecturers: Sara Makkeyah (Speaker); Maha Zakariya Mohammed (Speaker); Iman Ali El Agouza (Expert Faculty); Maha Zakariya Mohammed (Moderator)
When: January 17, 2026
Time: 9:00 - 10:00 AM Eastern Time ( US / Canada )
Click Here to Register
About Topic:
Revised NF1 Diagnostic Criteria (2021): An international consensus group updated guidelines, emphasizing the role of genetic testing
NF1 management has evolved from passive observation to active, personalized surveillance and targeted treatment. Genetic diagnosis enables early certainty, while MEK inhibitors offer the first effective medical treatments for hallmark tumors, fundamentally changing the clinical outlook for many patients.
Learning objectives:
1. To evaluate the genetic and molecular pathways relevant to NF1-associated conditions.
Revised NF1 Diagnostic Criteria (2021): An international consensus group updated guidelines, emphasizing the role of genetic testing
NF1 management has evolved from passive observation to active, personalized surveillance and targeted treatment. Genetic diagnosis enables early certainty, while MEK inhibitors offer the first effective medical treatments for hallmark tumors, fundamentally changing the clinical outlook for many patients.
Learning objectives:
1. To evaluate the genetic and molecular pathways relevant to NF1-associated conditions.
2. To incorporate new therapeutic approaches, such as MEK inhibitors, into treatment plans.
3. To formulate comprehensive management and supportive care strategies for long-term NF1 care.
4. To identify potential expanded indications and evaluate emerging targeted agents for NF1.
Add comment